PK and PD Interaction Between Tegoprazan and NOACs After Multiple Oral Dosing in Healthy Volunteers
Status:
Not yet recruiting
Trial end date:
2023-05-31
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the effects of combination therapy of tegoprazan and novel oral
anticoagulants (NOACs) on the pharmacokinetic and pharmacodynamic properties of NOACs in
healthy adults.